These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 8491028)
1. L-arginine in the clinical arena: tool or remedy? Lüscher TF; Haefeli WE Circulation; 1993 May; 87(5):1746-8. PubMed ID: 8491028 [No Abstract] [Full Text] [Related]
2. Positive and negative outcomes of L-arginine therapy in cardiovascular diseases. Herbaczyńska-Cedro K J Physiol Pharmacol; 1999 Dec; 50(4):653-60. PubMed ID: 10639015 [TBL] [Abstract][Full Text] [Related]
3. L-arginine in the management of cardiovascular diseases. Cheng JW; Baldwin SN Ann Pharmacother; 2001 Jun; 35(6):755-64. PubMed ID: 11408995 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic use of citrulline in cardiovascular disease. Romero MJ; Platt DH; Caldwell RB; Caldwell RW Cardiovasc Drug Rev; 2006; 24(3-4):275-90. PubMed ID: 17214603 [TBL] [Abstract][Full Text] [Related]
8. The clinical pharmacology of L-arginine. Böger RH; Bode-Böger SM Annu Rev Pharmacol Toxicol; 2001; 41():79-99. PubMed ID: 11264451 [TBL] [Abstract][Full Text] [Related]
9. Association of l-Arginine Supplementation with Markers of Endothelial Function in Patients with Cardiovascular or Metabolic Disorders: A Systematic Review and Meta-Analysis. Rodrigues-Krause J; Krause M; Rocha IMGD; Umpierre D; Fayh APT Nutrients; 2018 Dec; 11(1):. PubMed ID: 30577559 [TBL] [Abstract][Full Text] [Related]
11. The pharmacodynamics of L-arginine. Böger RH Altern Ther Health Med; 2014; 20(3):48-54. PubMed ID: 24755570 [TBL] [Abstract][Full Text] [Related]
12. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets? Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953 [TBL] [Abstract][Full Text] [Related]
13. Derangements of the nitric oxide synthase pathway, L-arginine, and cardiovascular diseases. Cooke JP; Dzau VJ Circulation; 1997 Jul; 96(2):379-82. PubMed ID: 9244195 [No Abstract] [Full Text] [Related]
14. L-Arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor. Böger RH; Ron ES Altern Med Rev; 2005 Mar; 10(1):14-23. PubMed ID: 15771559 [TBL] [Abstract][Full Text] [Related]
15. Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases. Böger RH; Bode-Böger SM Semin Thromb Hemost; 2000; 26(5):539-45. PubMed ID: 11129410 [TBL] [Abstract][Full Text] [Related]
16. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes. Tsikas D; Bollenbach A; Hanff E; Kayacelebi AA Cardiovasc Diabetol; 2018 Jan; 17(1):1. PubMed ID: 29301528 [TBL] [Abstract][Full Text] [Related]
17. [Pathophysiological and clinical aspects of using L-arginine in cardiology and angiology]. Valeev VV; Trashkov AP; Kovalenko AL; Vasil'ev AG Angiol Sosud Khir; 2016; 22(3):9-15. PubMed ID: 27626244 [TBL] [Abstract][Full Text] [Related]
18. Effect of L-arginine and selenium added to a hypocaloric diet enriched with legumes on cardiovascular disease risk factors in women with central obesity: a randomized, double-blind, placebo-controlled trial. Alizadeh M; Safaeiyan A; Ostadrahimi A; Estakhri R; Daneghian S; Ghaffari A; Gargari BP Ann Nutr Metab; 2012; 60(2):157-68. PubMed ID: 22517293 [TBL] [Abstract][Full Text] [Related]
19. [L-Arginine and vascular health]. Ströhle A; von Bibra H; Hahn A Med Monatsschr Pharm; 2016 Dec; 39(12):515-20. PubMed ID: 29979511 [TBL] [Abstract][Full Text] [Related]
20. Oxidative stress and asymmetric dimethylarginine are associated with cardiovascular complications in hemodialysis patients: improvements by L-arginine intake. El-Mesallamy HO; Abdel Hamid SG; Gad MZ Kidney Blood Press Res; 2008; 31(3):189-95. PubMed ID: 18511874 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]